• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Distribution and Evolution of H1N1 Influenza A Viruses with Adamantanes-Resistant Mutations Worldwide from 1918-2019

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Nov 17.
doi: 10.1002/jmv.26670. Online ahead of print.
Distribution and Evolution of H1N1 Influenza A Viruses with Adamantanes-Resistant Mutations Worldwide from 1918-2019


Weijun He[SUP] 1 [/SUP], Weixu Zhang[SUP] 1 [/SUP], Huixin Yan[SUP] 1 [/SUP], Hefeng Xu[SUP] 2 [/SUP], Yuan Xie[SUP] 1 [/SUP], Qizhong Wu[SUP] 1 [/SUP], Chengmin Wang[SUP] 3 [/SUP], Guoying Dong[SUP] 1 [/SUP]



Affiliations

Abstract

H1N1 influenza is a kind of acute respiratory infectious disease that has high socio-economic and medical burden each year around the world. In the past decades, H1N1 influenza viruses have exhibited high resistance to adamantanes, which has become a serious issue. In order to understand the up-to-date distribution and evolution of H1N1 influenza viruses with adamantanes-resistant mutations, we conducted a deep analysis of 15875 M2 protein and 8351 MP nucleotides sequences. Results of the distribution analyses showed that 77.32% of H1N1 influenza viruses harbored resistance mutations of which 73.52% were S31N, And the mutant variants mainly appeared in North America and Europe and H1N1 influenza viruses with S31N mutation became the circulating strains since 2009 all over the world; Additionally, 80.65% of human H1N1 influenza viruses and 74.61% of swine H1N1 influenza viruses exhibited adamantanes resistance, while the frequency was only 1.86% in avian H1N1 influenza viruses. Studies from evolutionary analyses indicated that the avian-origin swine H1N1 influenza viruses replaced the classical human H1N1 influenza viruses and became the circulating strains after 2009; The interspecies transmission among avian, swine and human strains over the past 20 years contributed to the 2009 Swine influenza pandemic. Results of our study clearly clarify the historical drug resistance level of H1N1 influenza viruses around the world and demonstrated the evolution of adamantanes-resistant mutations in H1N1 influenza viruses. Our findings emphasize the necessity for monitoring the adamantanes susceptibility of H1N1 influenza viruses and draw attention to analyses of the evolution of drug-resistant H1N1 influenza variants. This article is protected by copyright. All rights reserved.

Keywords: Adamantanes-Resistant Mutations; Distribution; Evolution.; H1N1 Influenza A Viruses.
 
Back
Top Bottom